TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 117 filers reported holding TCR2 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,170,000 | – | 255,044 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $34,473,000 | 7.99% |
| MPM BioImpact LLC | 3,370,982 | $28,687,000 | 4.45% |
| Ghost Tree Capital, LLC | 477,323 | $4,062,000 | 1.19% |
| Redmile Group, LLC | 3,816,709 | $32,480,000 | 0.57% |
| First Light Asset Management, LLC | 620,887 | $5,284,000 | 0.35% |
| AlphaCentric Advisors LLC | 113,000 | $962,000 | 0.24% |
| Cormorant Asset Management, LP | 479,506 | $4,081,000 | 0.17% |
| Artal Group S.A. | 750,000 | $6,383,000 | 0.14% |
| X-Square Capital, LLC | 32,003 | $272,000 | 0.14% |
| Altium Capital Management LP | 59,150 | $503,000 | 0.13% |